Artificial Intelligence has emerged as an integral force in the global digital health industry, transforming the way healthcare data is analyzed and diseases are diagnosed. AI and machine learning hold the promise of delivering more personalized and accessible healthcare. In this article, we will have a deeper look into some of the innovations AI technology … Continue reading How AI is Transforming Healthcare
Author: Biotechgate
6 AI-Driven Companies to Watch
Artificial intelligence (AI) is being rapidly integrated by life science companies seeking to reduce costs, become more efficient and enhance their automation, with this process only being spurred on by the COVID-19 pandemic. In this article, we’ve put together a list of companies to keep an eye on, with their operations centered on AI. 1. … Continue reading 6 AI-Driven Companies to Watch
How Biotechgate Uses Artificial Intelligence
At Biotechgate, we provide you with a comprehensive life sciences database, allowing users access to up-to-date information covering companies, licensing deals, financing rounds and more. We use a unique data-sourcing process to gather large amounts of information across the entire biopharma industry, giving Biotechgate users access to unprecedented information – thanks, in part, to artificial … Continue reading How Biotechgate Uses Artificial Intelligence
The Current State of M&A Activity in the Life Sciences Industry
The life sciences industry is no stranger to mergers and acquisitions (M&As), helping to expand product portfolios, access new markets and pursue new innovations, amongst a myriad of other reasons. In this article, we will look at the current state of M&A activity based on data from the Biotechgate database, with insights on where the … Continue reading The Current State of M&A Activity in the Life Sciences Industry
Life Sciences M&A Report: Half-Year 2023
In the first half of 2023, the slowdown in terms of global life sciences M&A deal-making experienced in the second half of 2022 has continued to show its effects. Anticipated as a year of recovery, 2023 was expected to leverage M&A as a means to adapt to rapidly changing market conditions. However, while it remains … Continue reading Life Sciences M&A Report: Half-Year 2023
Introducing M&A deals to Biotechgate
Biotechgate is continuously working on enhancements and new tools to boost the experience for our users. Currently, Biotechgate is developing a new release, which is planned for early 2024: Among the various new features that subscribers can look forward to, one in particular worth highlighting revolves around M&A deals and is unique on the market … Continue reading Introducing M&A deals to Biotechgate
Interoperability in Digital Health: Driving Innovation for Better Patient Care
Data interoperability in the digital health industry is more than just a buzzword: It stands for the potential to transform the way healthcare providers exchange electronic patient data. In this article, we will explore the importance of interoperability and the challenges it faces. Find out how to discover companies in Biotechgate that lead the development … Continue reading Interoperability in Digital Health: Driving Innovation for Better Patient Care
Financing in Digital Health: An Overview
Digital health is an industry in the life sciences experiencing constant innovation as well as attention from both investors and fellow companies. The Biotechgate Business Development Database contains an array of up-to-date information on digital health. In this article, you’ll find an overview of how funding in the industry has developed and further analysis of … Continue reading Financing in Digital Health: An Overview
Digital Health Categorization in Biotechgate Explained
Previously referred to as HealthTech, the digital health category is one of the six core company sectors in the Biotechgate database. Read our brief overview on what exactly this area consists of and how we define companies that fall under the digital health umbrella. The digital health sector does not always fit into the common … Continue reading Digital Health Categorization in Biotechgate Explained
Venture Valuation/Biotechgate and One Nucleus Partner to Boost Life Sciences Connectivity and Innovation
Zurich, Switzerland and Cambridge, UK, September 2023 – Biotechgate, a leading global life sciences business development and licensing database and One Nucleus, a Cambridge, UK-based life sciences and healthcare membership organisation, are thrilled to announce a collaboration to boost life sciences connectivity and innovation. The purpose of this collaboration is to provide a reliable hub … Continue reading Venture Valuation/Biotechgate and One Nucleus Partner to Boost Life Sciences Connectivity and Innovation